Ayrmid Ltd.
Activities of other holding companies n.e.c. · London
ActiveUnited KingdomIncorporated 2024Private Limited Company
Financial position
Accounts to 2025-12-31 · USD · Company accounts
Net assets
—
Cash
USD 6,000
Turnover
USD 2,831,000
Profit / loss
—
Current assets
USD 2,899,000
Creditors < 1 year
USD 4,472,000
Equity
—
Average employees
Not available
Balance-sheet trend
USD · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
Some figures were read by AI from scanned accounts, so small errors are possible. View the filed accounts
| Reported figures | 2025-12-31Company · AI-read | 2024-12-31Company · AI-read |
|---|---|---|
| Balance sheet | ||
| Share capital | USD 1,000 | USD 1,000 |
| Retained earnings | −USD 11,428,000 | −USD 8,155,000 |
| Assets | ||
| Fixed assets | USD 16,715,000 | USD 16,715,000 |
| Investments | USD 16,715,000 | USD 16,715,000 |
| Current assets | USD 2,899,000 | USD 692,000 |
| Cash at bank | USD 6,000 | — |
| Debtors | USD 2,841,000 | USD 651,000 |
| Liabilities | ||
| Creditors | USD 24,157,000 | USD 18,677,000 |
| Creditors within one year | USD 4,472,000 | USD 1,658,000 |
| Assets less current liabilities | USD 19,614,000 | USD 17,407,000 |
| Profit & loss | ||
| Turnover | USD 2,831,000 | USD 1,446,000 |
| Operating costs | ||
| Audit fees | USD 226,000 | USD 177,000 |
| Source evidence | View filing | View filing |
From the accounts
What the accounts for 2025-12-31 say about themselves, read by AI from the scanned filing.
- Going concern
- The directors report a material uncertainty about going concern
- Principal activity
- Ayrmid Ltd provides management services to one of its subsidiary companies, Gamida Cell Inc
- What it does
- management services · cell therapies (AI keywords)
- Outlook
- The Directors have no plans to significantly alter the activities of the Company for the foreseeable future
- Audit
- Subsidiary audit exemption, parent guarantee (s479A)
- Immediate parent
- Ayrmid Holdings Ltd · UK
- Ultimate parent
- JPMorgan Chase & Co · USA
- Ultimate controlling party
- Highbridge Capital Management, LLC
- Accounts
- FRS 101
- Approved
- 2026-06-11, signed by Joseph Wiley
Subsidiaries (3)
- Ayrmid Pharma Limited · 100 · Ireland · Cell therapies and management services
- Gamida Cell Ltd · 100 · Israel · Cell therapies
- Gamida Cell Inc · 100 · US · Cell therapies
Related parties (6)
- key management personnel · Directors Bradley Meyers and George Hampton, and chief executive officer Joe Wiley · Short term employee benefits · 1,078 (000s)
- key management personnel · Directors Bradley Meyers and George Hampton, and chief executive officer Joe Wiley · Performance related bonus · 553 (000s)
- key management personnel · Directors Bradley Meyers and George Hampton, and chief executive officer Joe Wiley · Total compensation · 1,631 (000s)
- key management personnel · Directors Bradley Meyers and George Hampton, and chief executive officer Joe Wiley · Short term employee benefits · 767 (000s)
- key management personnel · Directors Bradley Meyers and George Hampton, and chief executive officer Joe Wiley · Performance related bonus · 561 (000s)
- key management personnel · Directors Bradley Meyers and George Hampton, and chief executive officer Joe Wiley · Total compensation · 1,318 (000s)
Shares issued in the year (1)
- 100 ordinary shares
Directors' report (3)
- Bradley Meyer · appointed 2024-05-23
- George Hampton · appointed 2024-05-23
- Joseph Wiley · appointed 2024-05-23
Share classes (1)
- Not stated Ordinary Shares
Principal risks (4)
- Organisational Risk
- Competition Risk
- Funding Risk
- Risks Related to Our Group Business Operations
Events after the year end (1)
- Ayrmid Holdings Ltd (Immediate Parent) received equity from Highbridge totalling US$20,000,000 in January 2026.
Contingent liabilities (1)
- Contingent consideration relating to CVRs arising as a result of business combinations is recognized as a financial liability.
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
1 outstanding chargesFixed · created 2024-05-24
—
Outstanding